These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 33923612)

  • 1. Gut Microbiota and Environment in Coronary Artery Disease.
    Piccioni A; de Cunzo T; Valletta F; Covino M; Rinninella E; Raoul P; Zanza C; Mele MC; Franceschi F
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33923612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gut microbiota and its metabolite trimethylamine-N-oxide (TMAO): a novel regulator in coronary artery disease].
    Li Y; Cui M; Sun J; Wei Q; Liu M; Zhang J; Qi H; Zhao L; Fang H; Chen Z; Lü S
    Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3745-3756. PubMed ID: 34841781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease.
    Yoshida N; Sasaki K; Sasaki D; Yamashita T; Fukuda H; Hayashi T; Tabata T; Osawa R; Hirata KI; Kondo A
    J Atheroscler Thromb; 2019 Aug; 26(8):705-719. PubMed ID: 30587666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions.
    Trøseid M; Andersen GØ; Broch K; Hov JR
    EBioMedicine; 2020 Feb; 52():102649. PubMed ID: 32062353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Gut Microbiota and Trimethylamine N-oxide in Cardiovascular Diseases.
    Huang Y; Zhang H; Fan X; Wang J; Yin Y; Zhang Y; Shi K; Yu F
    J Cardiovasc Transl Res; 2023 Jun; 16(3):581-589. PubMed ID: 36251229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of gut microbiome on coronary artery disease.
    Xu J; Yang Y
    Cardiovasc Diagn Ther; 2020 Aug; 10(4):869-880. PubMed ID: 32968642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Gut Microbiota in Coronary Artery Disease Patients: a Possible Link between Gut Microbiota and Coronary Artery Disease.
    Emoto T; Yamashita T; Sasaki N; Hirota Y; Hayashi T; So A; Kasahara K; Yodoi K; Matsumoto T; Mizoguchi T; Ogawa W; Hirata K
    J Atheroscler Thromb; 2016 Aug; 23(8):908-21. PubMed ID: 26947598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease.
    Emoto T; Yamashita T; Kobayashi T; Sasaki N; Hirota Y; Hayashi T; So A; Kasahara K; Yodoi K; Matsumoto T; Mizoguchi T; Ogawa W; Hirata KI
    Heart Vessels; 2017 Jan; 32(1):39-46. PubMed ID: 27125213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota from coronary artery disease patients contributes to vascular dysfunction in mice by regulating bile acid metabolism and immune activation.
    Liu H; Tian R; Wang H; Feng S; Li H; Xiao Y; Luan X; Zhang Z; Shi N; Niu H; Zhang S
    J Transl Med; 2020 Oct; 18(1):382. PubMed ID: 33036625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota in coronary artery disease: a friend or foe?
    Zhang B; Wang X; Xia R; Li C
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32352513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota metabolic characteristics in coronary artery disease patients with hyperhomocysteine.
    Tian R; Liu HH; Feng SQ; Wang YF; Wang YY; Chen YX; Wang H; Zhang SY
    J Microbiol; 2022 Apr; 60(4):419-428. PubMed ID: 35246806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between polysaccharides and gut microbiota: A metabolomic and microbial review.
    Zhang D; Liu J; Cheng H; Wang H; Tan Y; Feng W; Peng C
    Food Res Int; 2022 Oct; 160():111653. PubMed ID: 36076442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysbiosis signatures of gut microbiota in coronary artery disease.
    Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H
    Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Gut Microbiota on Cardio-Metabolic Parameters and Immunity in Coronary Artery Disease Patients with and without Type-2 Diabetes Mellitus.
    Sanchez-Alcoholado L; Castellano-Castillo D; Jordán-Martínez L; Moreno-Indias I; Cardila-Cruz P; Elena D; Muñoz-Garcia AJ; Queipo-Ortuño MI; Jimenez-Navarro M
    Front Microbiol; 2017; 8():1936. PubMed ID: 29051757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distal colonic transit is linked to gut microbiota diversity and microbial fermentation in humans with slow colonic transit.
    Müller M; Hermes GDA; Canfora EE; Smidt H; Masclee AAM; Zoetendal EG; Blaak EE
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G361-G369. PubMed ID: 31869241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of L-carnitine and phosphatidylcholine containing products on the proatherogenic metabolite TMAO production and gut microbiome changes in patients with coronary artery disease].
    Ivashkin VT; Kashukh YA
    Vopr Pitan; 2019; 88(4):25-33. PubMed ID: 31722138
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM).
    Tanase DM; Gosav EM; Neculae E; Costea CF; Ciocoiu M; Hurjui LL; Tarniceriu CC; Maranduca MA; Lacatusu CM; Floria M; Serban IL
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33276482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
    Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
    [No Abstract]   [Full Text] [Related]  

  • 19. Transplantation of fecal microbiota rich in short chain fatty acids and butyric acid treat cerebral ischemic stroke by regulating gut microbiota.
    Chen R; Xu Y; Wu P; Zhou H; Lasanajak Y; Fang Y; Tang L; Ye L; Li X; Cai Z; Zhao J
    Pharmacol Res; 2019 Oct; 148():104403. PubMed ID: 31425750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short chain fatty acids contribute to gut microbiota-induced promotion of colonic melatonin receptor expression.
    Wang B; Zhang L; Zhu SW; Zhang JD; Duan LP
    J Biol Regul Homeost Agents; 2019; 33(3):763-771. PubMed ID: 31204469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.